Comparison of modified-release hydrocortisone capsules versus prednisolone in the treatment of congenital adrenal hyperplasia.
Aled Daffyd ReesDeborah P MerkeWiebke ArltAude Brac De La PerriereAngelica Linden HirschbergAnders JuulJohn Newell-PriceAlessandro PreteNicole ReischNike M StikkelbroeckPhilippe A TouraineAlex LewisJohn PorterHelen CoopeRichard J RossPublished in: Endocrine connections (2024)
MRHC reduces 17OHP at 09:00 h compared to prednis(ol)one and the dose of MRHC can be down-titrated over time in the majority of patients.